Impact of evolving treatment patterns on interstitial lung disease progression in systemic sclerosis using the EUSTAR database

By afschroeder • January 23, 2026

Campochiaro C, Truchetet ME, Vonk M, De Luca G, Cuomo G, Ananieva LP, Hachulla E, Smith V, Gheorghiu AM, Becvar R, Carreira P, Hunzelmann N, Furst DE, Ortiz-Santamaria V, Del Galdo F, Matucci-Cerinic M, Hoffmann-Vold AM; EUSTAR collaborators. Impact of evolving treatment patterns on interstitial lung disease progression in systemic sclerosis using the EUSTAR database. Arthritis Rheumatol. 2026 Jan 22. doi: 10.1002/art.70043. Epub ahead of print. PMID: 41568546.

Tags: Publications, Rheumatology

Nuclear mechanobiology: a brief history and five unresolved questions

Lammerding J, Eeftens J, Gundersen GG, King MC, Lele TP, Li S, Luxton G W G, Medalia O, Piel M, Roca-Cusachs P, Renkawitz J, Roux[...]

Feasibility of Using Clinicians to Code the Actionability of Narrative Comments About Patient Experience for Quality Improvement

Quigley DD, Predmore Z, Panayotou MS, Elliott MN, Hays RD. Feasibility of Using Clinicians to Code the Actionability of Narrative Comments About Patient Experience for[...]

Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE

Rugo HS, Tolaney SM, Chan N, Borges G, Yerushalmi R, Sharifi MN, McHayleh W, Beck T, Vidula N, Hamilton E, Rinn KJ, O'Shaughnessy J, Curigliano[...]